The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases-Reference-Cited by-同舟云学术

The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases

Published:2017-07 Issue:6 Volume:28 Page:669-675
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Kaidar-Person Orit,Zagar Timothy M.,Deal Allison,Moschos Stergios J.,Ewend Matthew G.,Sasaki-Adams Deanna,Lee Carrie B.,Collichio Frances A.,Fried David,Marks Lawrence B.,Chera Bhishamjit S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference26 articles.

1. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases;Selek;Int J Radiat Oncol Biol Phys,2004

2. Stereotactic radiosurgery for patients with ‘radioresistant’ brain metastases;Brown;Neurosurgery,2002

3. Does immunotherapy increase the rate of radiation necrosis after radiosurgical treatment of brain metastases?;Colaco;J Neurosurg,2016

4. BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis;Patel;Melanoma Res,2016

5. Two heads better than one? ipilimumab immunotherapy and radiation therapy for melanoma brain metastases;Patel;Neuro Oncol,2015

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of Stimulator of Interferon Genes (STING): Promising Strategy to Overcome Immune Resistance in Prostate Cancer;Current Medicinal Chemistry;2024-12

2. Which is the best treatment for melanoma brain metastases? A Bayesian network meta-analysis and systematic review;Critical Reviews in Oncology/Hematology;2024-02

3. Immunotherapeutic Strategies for Intra-cranial Metastatic Melanoma - a Meta-analysis and Systematic Review;Journal of Cancer;2024

4. Local Control and Toxicity after Stereotactic Radiotherapy in Brain Metastases Patients and the Impact of Novel Systemic Treatments;2024

5. The Impact of Immune Checkpoint Inhibition on the Risk of Radiation Necrosis Following Stereotactic Radiotherapy for Metastatic Brain Cancer;Cureus;2023-12-31